Axon Enterprise stock performance snapshot

Axon Enterprise (AXON) has drawn attention after recent trading, with the stock closing at US$380.60 and showing negative returns over the past week, month and past 3 months, alongside a negative 1 year total return.

Recent trading has been weak, with a 1 month share price return of a 7.86% decline, adding to a 32.45% decline year to date, even though the 5 year total shareholder return is 206.71%. As a result, recent momentum is fading against a stronger long term record.

If Axon’s pullback has you thinking about where else capital might work hard for you, this could be a good moment to scan 19 top founder-led companies

With Axon increasing revenue and net income, and the stock pulling back despite a 5 year total shareholder return above 200%, the key question now is whether you are getting a bargain or if the market is already pricing in future growth.

Most Popular Narrative: 37.3% Undervalued

Axon’s widely followed narrative pegs fair value at $606.83, well above the last close at $380.60. This sets a very different anchor to the current market price.

One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.

This narrative, according to AryaWinningSon, leans heavily on Axon’s shift toward recurring software and data revenue, as well as an embedded role in public safety workflows that underpins the valuation story.

Result: Fair Value of $606.83 (UNDERVALUED)

However, this story can be challenged if public safety budgets tighten or if new competitors offer better terms on bundled hardware and software contracts, which would pressure Axon’s ecosystem.

Another angle on Axon’s valuation

The user narrative flags Axon as 37.3% undervalued at a fair value of $606.83, yet our DCF model points to something tighter, with fair value at $364.55 versus the $380.60 share price, implying a small premium instead of a big discount. Which story do you think fits your own expectations?

Next Steps

With mixed signals across returns and valuation, the real question is what matters most to you right now. Move quickly to review both the reward and risk data in detail and decide where you stand using our summary of 1 key reward and 3 important warning signs

Looking for more investment ideas?

If Axon has sharpened your focus on quality, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.

• Target potential mispricing by scanning 51 high quality undervalued stocks that combine strong fundamentals with prices that may sit below their fair value estimates.
• Lock in income-focused opportunities by reviewing 13 dividend fortresses that pair sizeable yields with an emphasis on resilience.
• Front run the crowd by checking the screener containing 25 high quality undiscovered gems before they attract wider attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.